Exchange: NASDAQ·Updated 07:30 PM EDT
PRME logo

PRME Prime Medicine Inc

$3.38
$0.09
(2.53%)
Today
Closed $3.47
$0.09
(2.59%)
After Hours
EarningsNov 6
Mkt Cap$645.7M
Vol4.23M

About PRME

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
47

Neutral Sentiment

How do you feel about PRME?

Advertisement|Remove ads.